BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

BTIG initiated coverage of VYNE Therapeutics (VYNE) with a Buy rating and $8 price target VYNE is pioneering the development ...

Fintel reports that on November 18, 2024, BTIG initiated coverage of VYNE Therapeutics (NasdaqCM:VYNE) with a Buy ...

BTIG raised the firm’s price target on Syndax (SNDX) to $43 from $35 and keeps a Buy rating on the shares. The firm cites the company having ...

Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

On Thursday, Opendoor Technologies Inc (OPEN) stock saw a decline, ending the day at $1.77 which represents a decrease of $-0.04 or -2.21% from the prior close of $1.81. The stock opened at $1.81 and ...

Plug Power (NASDAQ:PLUG) -1.1% in Thursday's trading as BTIG Research downgrades shares to Neutral from Buy, saying the company is "turning the corner but still [has] a lot of work to do." ...

BTIG analyst Gregory Lewis lowered the firm’s price target on Bloom Energy (BE) to $16 from $21 and keeps a Buy rating on the ...

Consumer Retail and Lifestyle Brands Analyst Stichter holds a group meeting and store tour with CEO Conroy, CFO Watkins and Chief Digital Officer Hazen in Nashville on November 19 hosted by BTIG.

BTIG is “struggling to find any good reason” for why Paysafe (PSFE) is trading down 25% today following its Q3 earnings report. The report was solid with top- and bottom-line beats and a ...